Recent studies by the Institute for Health Metrics and Evaluation (IHME) draw attention to the growing threat of antibiotic resistance across the globe, notably impacting children due to their comparatively weaker immune systems. In an engaging conversation, Dr. Gisela Robles Aguilar of the University of Oxford offered keen insights into the crisis, as well as potential strategies for its mitigation.
Drawing largely from her recent research on antibiotic resistance in the WHO Region of the Americas, Dr. Aguilar highlighted alarmingly that over two in every five infection-related deaths were linked to antibiotic resistance. She underlined the criticality of the situation, pointing out that the overuse of antibiotics was giving rise to resistant strains of bacteria. With the most recent class of antibiotics emerging in the 1980s and none developed since, healthcare practitioners are progressively losing their arsenal to fight these infectious invaders.
Dr. Aguilar flagged that children with compromised immune systems, particularly neonates, are at a significant risk of contracting antibiotic-resistant infections. As these young ones grow, their immunity system strengthens, usually through breastfeeding, gradually improving their protective shield against bacteria. However, the aged, those with weak immunity, and individuals undergoing surgeries become particularly vulnerable to these infections.
Preventive measures include adhering to infection control guidelines, ensuring access to clean water and sanitation, and boosting immunization efforts against infections. For instance, vaccination campaigns significantly decrease the chances of contracting infections, thereby further reducing the likelihood of bacteria acquiring resistance.
The conversation also turned towards the limitations of current selection of vaccines. So far, only two of the deadliest antibiotic-resistant bacteria – pneumococcal disease and tuberculosis – have vaccine protections, while others remain at an experimentation stage. The gap in accessible vaccines is largely due to insufficient data on the potential impact of such interventions. However, Dr. Aguilar believes there’s an urgent need for these vaccines to enter the public realm as a proactive measure against antibiotic resistance.
In terms of solutions, Dr. Aguilar supports WHO’s strategy emphasizing infection prevention and control. Critical actions include monitoring antibiotic usage in healthcare settings and pharmacies, thus enabling the tracking of emerging resistances. This would assist in strategizing antibiotic usage, reducing chances of resistance.
The conversation concluded with insights into high-performing countries like Chile, Colombia, Costa Rica, and the US, which have succeeded in maintaining low levels of death due to drug-resistant infections, primarily through judicious antibiotic use and robust infection prevention measures. Meanwhile, nations like the Dominican Republic and Venezuela face higher infant mortality rates due to drug-resistant infections, pointing towards the urgent need for collective international efforts in controlling the crisis.